Growing community of inventors

San Carlos, CA, United States of America

Nicholas Van Bruggen

Average Co-Inventor Count = 2.92

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 19

Nicholas Van BruggenNapoleone Ferrara (3 patents)Nicholas Van BruggenRichard L Vandlen (2 patents)Nicholas Van BruggenJustin M Scheer (2 patents)Nicholas Van BruggenPhilip E Hass (2 patents)Nicholas Van BruggenWenjun Ouyang (2 patents)Nicholas Van BruggenXiaoting Wang (2 patents)Nicholas Van BruggenEric Gary Stefanich (2 patents)Nicholas Van BruggenGanesh A Kolumam (2 patents)Nicholas Van BruggenWyne Pun Lee (1 patent)Nicholas Van BruggenJustin Scheer (3 patents)Nicholas Van BruggenJed Ross (2 patents)Nicholas Van BruggenPhilip E Haas (0 patent)Nicholas Van BruggenNicholas Van Bruggen (5 patents)Napoleone FerraraNapoleone Ferrara (104 patents)Richard L VandlenRichard L Vandlen (38 patents)Justin M ScheerJustin M Scheer (30 patents)Philip E HassPhilip E Hass (25 patents)Wenjun OuyangWenjun Ouyang (15 patents)Xiaoting WangXiaoting Wang (9 patents)Eric Gary StefanichEric Gary Stefanich (9 patents)Ganesh A KolumamGanesh A Kolumam (4 patents)Wyne Pun LeeWyne Pun Lee (4 patents)Justin ScheerJustin Scheer (3 patents)Jed RossJed Ross (2 patents)Philip E HaasPhilip E Haas (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Genentech, Inc. (5 from 3,221 patents)


5 patents:

1. 11136365 - Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins

2. 10584155 - Pharmaceutical compositions of IL-22 Fc fusion proteins

3. 8287873 - Vascular endothelial cell growth factor antagonists and uses thereof

4. 8007799 - Vascular endothelial cell growth factor antagonists and uses thereof

5. 7998931 - Vascular endothelial cell growth factor antagonists and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…